Transition at the Top: How will the landscape change?

MASTERS OF THE UNIVERSEJim MazzoExecutive Chairman & CEOAcuFocus

Moderated By:Mike BallCEOAlcon

Participants:Tom FrinziPresident AMOSVP Abbott Laboratories

William J. Link, PhDManaging DirectorVersant Ventures

William MeuryEVP, President Branded PharmaAllergan

Ludwin Monz, PhDPresident & CEOCarl Zeiss Meditec AG

Calvin Roberts, MDSVP & Chief Medical OfficerBausch + Lomb

Ashley McEvoyCompany Group ChairmanJohnson & Johnson Vision Care

1

Transition: How Will the Landscape Change?Jim MazzoChairman and CEO AcuFocusOIS @ ASCRS 2016

2

When Art Imitates Life

3

When Games Become Reality

4

Ophthalmology Strategic Landscape: 20 Years Ago5NestleAllerganBausch & Lomb

VISXAlconJohnson & Johnson Zeiss

Ophthalmology Strategic Landscape: 15 Years Ago6AlconAMOAllerganBausch & LombZeiss

WavelightVISXIntraLaseWavefront SciencesJohnson & Johnson

Ophthalmology Strategic Landscape: 10 Years Ago7AlconAMOBausch & Lomb Warburg Pincus

AllerganZeissJohnson & Johnson

Todays Ophthalmology Strategic LandscapeZeiss

AMO

Alcon

B&LGlaukos

TranscendTear ScienceAcuFocusShire

Aerie Pharmaceuticals

Aquesys

Masters of the Universe PanelLudwin Monz, PhDPresident & CEO, Carl Zeiss Meditec AG

9

Mike BallCEO, Alcon

Tom FrinziPresident AMO, Senior VP Abbott Laboratories

William J. Link, PhDManaging Director, Versant VenturesCalvin W. Roberts, MDSenior VP & Chief Medical Officer, Bausch & LombAshley McEvoyCompany Group Chairman, Johnson & Johnson Vision Care

William MeuryEVP & President, Branded Pharma, Allergan

CLOSING REMARKS

Emmett T. Cunningham, MD, PhD, MPHPartnerClarus Ventures

15